YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Tysabri

Tysabri Getting More Scrutiny Over Brain Infection

Oct 26, 2009 | Parker Waichman Alonso LLP
European regulators are taking another look at Tysabri.  According to The Wall Street Journal, the European Medicines Agency's Committee for...

Tysabri-PML Link Will Weigh on Biogen Stock, Report Says

Sep 23, 2009 | Parker Waichman Alonso LLP
Tysabri troubles could continue to cause a drag on Biogen Idec stock, according to a Wall Street Journal report.  A recently released research...

Tysabri Safety Info Now Includes PML Cases

Sep 17, 2009 | Parker Waichman Alonso LLP
The Food & Drug Administration (FDA) is updating Tysabri safety information to include cases of progressive multifocal leukoencephalopathy or...

Brain Infection Reported in More Tysabri Patients

Sep 15, 2009 | Parker Waichman Alonso LLP
Two more Tysabri patients have developed progressive multifocal leukoencephalopathy or PML.  Both new cases occurred in European patients,...

10th Tysabri Patient Stricken with PML

Jun 30, 2009 | Parker Waichman Alonso LLP
Another Tysabri patient has developed progressive multifocal leukoencephalopathy or PML. This brings the total number of cases of the brain infection...

Another Tysabri Patient Stricken with PML

Jun 15, 2009 | Parker Waichman Alonso LLP
Tysabri,  a drug used to treat multiple sclerosis, has been linked to  another case of progressive multifocal leukoencephalopathy, or...

Tysabri, Plavix Sponsored Link Promotions Criticized

Apr 6, 2009 | Parker Waichman Alonso LLP
The makers of Tysabri and Plavix have been warned about internet ads for the drugs.  According to the Food & Drug Administration (FDA), the...

Tysabri Linked to Another Case of PML

Oct 30, 2008 | Parker Waichman Alonso LLP
Another Tysabri patient has developed progressive multifocal leukoencephalopathy (PML), an often fatal brain disease.  Just three months ago,...

Tysabri Labeling Changes Sought by European Regulators

Sep 25, 2008 | Parker Waichman Alonso LLP
The European Medicines Agency wants to raise awareness of a deadly brain infection associated with the drug Tysabri.  It recommended Thursday...

New Tysabri Trials Underway, Despite Serious Risks

Sep 8, 2008 | Parker Waichman Alonso LLP
Despite the fact that it has been tied to a deadly brain infection, and is being investigated for a possible link to melanoma,  the makers of...

Page 1/4 [first] [prev] 1 2 3 4 [next] [last]

Tysabri
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News